(Q37947242)

25 August 2017

title

Inflammatory markers in coronary heart disease (English)

1 reference

25 August 2017

0 references

Mohammad Madjid

1

1 reference

25 August 2017

James T Willerson

series ordinal

2

1 reference

25 August 2017

publication date

18 October 2011

1 reference

25 August 2017

published in

British Medical Bulletin

1 reference

25 August 2017

volume

100

1 reference

25 August 2017

page(s)

23-38

1 reference

Atherosclerosis — An Inflammatory Disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paper.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

C-reactive protein and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Insight into the nature of the CRP-coronary event association using Mendelian randomization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Multiple biomarkers for the prediction of first major cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, dou

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Leukocyte count and coronary heart disease: implications for risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Soluble CD40L and cardiovascular risk in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Cystatin C and the risk of death and cardiovascular events among elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBMB%2FLDR043

21 January 2018

Identifiers

DOI

10.1093/BMB/LDR043

1 reference

25 August 2017

1 reference